NaCl enhances CD8+ T cell effector functions in cancer immunotherapy
- PMID: 39198631
- DOI: 10.1038/s41590-024-01923-9
NaCl enhances CD8+ T cell effector functions in cancer immunotherapy
Abstract
CD8+ T cells control tumors but inevitably become dysfunctional in the tumor microenvironment. Here, we show that sodium chloride (NaCl) counteracts T cell dysfunction to promote cancer regression. NaCl supplementation during CD8+ T cell culture induced effector differentiation, IFN-γ production and cytotoxicity while maintaining the gene networks responsible for stem-like plasticity. Accordingly, adoptive transfer of tumor-specific T cells resulted in superior anti-tumor immunity in a humanized mouse model. In mice, a high-salt diet reduced the growth of experimental tumors in a CD8+ T cell-dependent manner by inhibiting terminal differentiation and enhancing the effector potency of CD8+ T cells. Mechanistically, NaCl enhanced glutamine consumption, which was critical for transcriptional, epigenetic and functional reprogramming. In humans, CD8+ T cells undergoing antigen recognition in tumors and predicting favorable responses to checkpoint blockade immunotherapy resembled those induced by NaCl. Thus, NaCl metabolism is a regulator of CD8+ T cell effector function, with potential implications for cancer immunotherapy.
© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.
References
MeSH terms
Substances
Grants and funding
- AIRC IG 2017 - ID 20676/Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research)
- AIRC IG 2022 - ID 27391/Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research)
- AIRC 5×1000 program UniCanVax 22757/Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research)
- AIRC/FIRC fellowship/Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research)
- CRI Lloyd J. Old STAR (CRI award 3914)/Cancer Research Institute (CRI)